RECTUM CANCER
Clinical trials for RECTUM CANCER explained in plain language.
Never miss a new study
Get alerted when new RECTUM CANCER trials appear
Sign up with your email to follow new studies for RECTUM CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor immune cells get a boost in new cancer trial
Disease control TerminatedThis early-phase study tests whether giving healthy donor NK cells along with two medicines (vactosertib and IL-2) is safe and helps the cells stay active in people with advanced colorectal, stomach, esophageal, or blood cancers. The NK cells are meant to attack cancer, but the b…
Matched conditions: RECTUM CANCER
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New combo shows promise for Hard-to-Treat colorectal cancer
Disease control OngoingThis phase 2 trial is testing a combination of two drugs, cabozantinib and nivolumab, in 48 people with advanced colorectal cancer that has not responded to standard treatments. The goal is to see if the combination can shrink or stabilize tumors. All participants have a type of …
Matched conditions: RECTUM CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New program aims to ease mental and physical side effects of immunotherapy
Symptom relief OngoingThis study tests a personalized self-management program to help cancer survivors on immune checkpoint inhibitors better handle side effects and reduce anxiety or depression. About 400 adults with breast, colon, lung, skin, or rectal cancer who recently started immunotherapy will …
Matched conditions: RECTUM CANCER
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC